This ones a heck of a specualive investment but it seems that the institutions are willing to stomp up the cash to back it in the long term.

Heres the latest news from Killik stocbrokers on the company..........

MEDICAL MARKETING Joint Venture

We recently highlighted Medical Marketing (MMG) as worthy of attention. The company, in which I have a personal share holding, has this morning announced the formation of a joint venture, Genvax, to develop a novel DNA vaccine platform technology.

Human trials have been underway since 2001 in areas such as Lymphoma and Myeloma but the technology has broad applications in cancer, viral and bacterial infections (hence the term platform). The technology works on boosting the immune system by teaching it to identify hard to recognise cancer proteins as foreign and destroy them. Early results from the 25 patient trial in lymphoma are encouraging and evaluation of the result is expected by March 2005. Successful results should mean big pharmaceutical groups will start to take financial and commercial interests around that time.

This looks to be the first of a series of announcements due from Medical Marketing as it has a range of predominantly cancer trials moving into the clinical stage. (news flow could push the price higher)

The stock has made good progress in recent sessions up to the mid-80p level where the company is valued at just under 40 million. ENDS.

Please DYOR

cheers GF.

Im hoping that we have further news before the Agm which could push the price much higher..it could be the news were waiting for..

Looks like you know something Mitzy.

cheers GF.

It is just a hunch GF....

Ill bet.

cheers GF.

Probably one of the most risky shares I have held in 20 years of investing and trading, but I hope it comes good.

cheers GF.

morning folks

I am a long term holder of mmg since the 'bioscience innovation day's on ofex.

Your right goldfinger it is risky (although not compared to some of the dross i have held in the past)but it is constantly consolidating into a tidy little well run company.
My only regret with this one is that I did not top up at 2pence. It actually represents 50 p/c of my actively traded portfolio (8 stocks) which i know is to much but I do like the stock.

I think we could be in for a good day today but I am looking long term for the big institution interest which I am confident will come considering the gravity of the treatments undergoing research.

good luck.. rob

Nice to see you here rob, yes it could with a little push from the institutions.

It is up as I sapeak.

cheers GF.

Medical Marketing extends Edinburgh ruthenium cancer drug licensing deal
AFX


LONDON (AFX) - Medical Marketing International Group PLC said it has signed a deal with Edinburgh University, extending its licence to develop cancer drugs based on the precious metal Ruthenium.

MMI said it has exercised an option extending a 2002 agreement between its cancer subsidiary Oncosense and Edinburgh University.

It said the patent portfolio covers thousands of potential compounds. More than 140 compounds have already been tested against human cell lines, including those resistant to platinum-based drugs.

MMI said 12 lead compounds with significant activity have already been identified, and clinical trials candidate compounds will be chosen shortly.

email: newsdesk@afxnews.com

jm/


cheers GF.

Has the brokers note been issued?

Yup was this monday, BUY was the recommendation.

Asked Mitzy if he could get some more detail , awaiting developments.

cheers GF.

Todays small cap fall gives you a chance to pick these up on the cheap.

cheers GF.

we may hit a lower resistance at about 63/64 pence. I suspect this may be a good buying opportunity (dyor). The graphs suggest it could bounce again from this level. good luck.......Rob

I would agree with that Rob, we just need a bit of news flow.

cheers GF.

Looks like 60p on the cards

Fear not the news will be out and it will be good...

50k sell 8 trading days before agm mmmmmmm

50k sell could have been activated by trigger happy stop-loss.
the price is hovering around lower support line. This stock obviously moves heavily on news but also take a look at how it tracks(albeit with greater swings) the big indeces.
I have been in this stock for a long time and will continue to be.
Do some research and see how much,and the nature of the r&d that the various components of mmg are involved in. It is nothing short of mind-blowing.
I think that despite some press reports it has still to be 'discovered'.
Dyor Good luck. Rob

rob308, totally agree and sticking with mizty and gf on this one, took advantage with top up again in recent days. Enjoying the wait!!

Good point there Rob about it still as to be discovered.

When it eventually does attract a wider audience, Im sure we will se a big re- rating.

cheers GF.

Anyone have any up to date news from the Mike Walters site?.

cheers GF.